X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1602) 1602
Publication (193) 193
Book Review (10) 10
Book Chapter (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (847) 847
animals (843) 843
oxadiazoles - pharmacology (843) 843
index medicus (744) 744
male (707) 707
oxadiazoles - therapeutic use (610) 610
pharmacology & pharmacy (443) 443
rats (392) 392
female (391) 391
mice (291) 291
dose-response relationship, drug (252) 252
middle aged (246) 246
oxadiazoles - chemistry (244) 244
chemistry, medicinal (227) 227
quinoxalines - pharmacology (210) 210
adult (204) 204
aged (171) 171
enzyme inhibitors - pharmacology (167) 167
nitric oxide (160) 160
structure-activity relationship (151) 151
oxadiazoles - chemical synthesis (148) 148
analysis (146) 146
oxadiazoles - administration & dosage (141) 141
in vitro techniques (140) 140
rats, wistar (128) 128
neurosciences (126) 126
biochemistry & molecular biology (123) 123
sydnones - therapeutic use (121) 121
blood pressure - drug effects (118) 118
time factors (107) 107
derivatives (104) 104
guanylate cyclase - antagonists & inhibitors (102) 102
molecular structure (102) 102
molsidomine (98) 98
rats, sprague-dawley (98) 98
cell line, tumor (97) 97
chemistry, organic (95) 95
disease models, animal (95) 95
oxadiazoles - adverse effects (91) 91
oxadiazoles (88) 88
cancer (87) 87
inhibitors (87) 87
nitric oxide - metabolism (87) 87
vasodilator agents - therapeutic use (86) 86
vasodilator agents - pharmacology (83) 83
hypertension - drug therapy (80) 80
clinical trials as topic (79) 79
ng-nitroarginine methyl ester - pharmacology (79) 79
double-blind method (78) 78
treatment outcome (77) 77
article (76) 76
in-vitro (76) 76
oxadiazoles - pharmacokinetics (76) 76
pharmacology (76) 76
nitric-oxide (75) 75
oxadiazole (74) 74
activation (72) 72
mice, inbred c57bl (72) 72
cyclic gmp - metabolism (71) 71
hemodynamics - drug effects (70) 70
hypertension (69) 69
benzimidazoles - therapeutic use (68) 68
cells, cultured (68) 68
inhibition (68) 68
piperazines - pharmacology (68) 68
pyridines - pharmacology (67) 67
apoptosis (66) 66
antineoplastic agents - pharmacology (64) 64
design (63) 63
cells (62) 62
nitric oxide donors - pharmacology (61) 61
vasodilation - drug effects (61) 61
angina pectoris - drug therapy (60) 60
antiviral agents - therapeutic use (60) 60
cell biology (60) 60
rodents (60) 60
drug therapy (58) 58
expression (58) 58
antihypertensive agents - therapeutic use (57) 57
drugs (57) 57
pharmacology/toxicology (57) 57
research (57) 57
adolescent (56) 56
biological evaluation (56) 56
care and treatment (56) 56
heart rate - drug effects (56) 56
health aspects (55) 55
physiology (54) 54
signal transduction - drug effects (54) 54
cell proliferation - drug effects (53) 53
nitric oxide - physiology (53) 53
drug design (52) 52
drug evaluation, preclinical (51) 51
oxadiazoles - metabolism (51) 51
proteins (51) 51
administration, oral (50) 50
dogs (50) 50
drug discovery (50) 50
antineoplastic agents - chemistry (49) 49
biomedicine (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1395) 1395
German (52) 52
Italian (52) 52
Russian (45) 45
French (35) 35
Spanish (9) 9
Japanese (8) 8
Polish (7) 7
Chinese (3) 3
Czech (3) 3
Bulgarian (2) 2
Hungarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Hypertension, ISSN 0194-911X, 02/2015, Volume 65, Issue 2, pp. 401 - 406
Journal Article
Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 02/2015, Volume 277, Issue 2, pp. 155 - 166
Cystic fibrosis (CF) is the most common genetic life‐shortening condition in Caucasians. Despite being a multi‐organ disease, CF is classically diagnosed by... 
rare diseases | monogenic disorder | mutation‐specific therapies | personalized therapy | Rare diseases | Monogenic disorder | Personalized therapy | Mutation-specific therapies | CFTR MUTATIONS | GENE-MUTATIONS | PROTEIN | GENOTYPE-PHENOTYPE CORRELATIONS | F508DEL-CFTR | IDENTIFICATION | PLASMA-MEMBRANE | TRANSMEMBRANE CONDUCTANCE REGULATOR | MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | LUNG-DISEASE | mutation-specific therapies | Severity of Illness Index | Cystic Fibrosis - blood | Frameshift Mutation | Sweat Glands - drug effects | Humans | Aminophenols - therapeutic use | Rare Diseases | Biomarkers - blood | Codon, Nonsense | Evidence-Based Medicine | Oxadiazoles - therapeutic use | Purinergic Antagonists - therapeutic use | Anti-Bacterial Agents - therapeutic use | Phenotype | Cystic Fibrosis - genetics | Quinolones - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Cystic Fibrosis - diagnosis | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Genistein - therapeutic use | Cystic Fibrosis - mortality | Cystic Fibrosis - drug therapy | Aminoglycosides - therapeutic use | Precision Medicine | Cystic fibrosis | Care and treatment | Medical research | Lung diseases | Clinical trials | Mucus | Environmental factors | Patients | Defects | Proteins | Resistance | Antibiotics | Respiratory diseases | Fibrosis | Conductance | Sweat
Journal Article
Hypertension, ISSN 0194-911X, 08/2012, Volume 60, Issue 2, pp. 310 - 318
Journal Article